Immunogenicity of COVID ‐19 vaccines in patients with follicular lymphoma receiving frontline chemoimmunotherapy
Summary: Immune responses to primary COVID‐19 vaccination were investigated in 58 patients with follicular lymphoma (FL) as part of the PETReA trial of frontline therapy (EudraCT 2016–004010‐10). COVID‐19 vaccines (BNT162b2 or ChAdOx1) were administered before, during or after cytoreductive treatmen...
主要な著者: | Lim, YJ, Ward, V, Brown, A, Phillips, E, Kronsteiner, B, Malone, T, Jennings, D, Healy, S, Longet, S, James, T, Thomson, P, Farrell, L, Oates, M, Jackson, R, Morrison, A, Burns, M, Carroll, M, Klenerman, P, Turtle, L, Naisbitt, D, Rhodes, M, Robinson, K, Gatto, S, Young, M, Eyre, TA, Eyre, DW, Dunachie, S, Barnes, E |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
Wiley
2024
|
類似資料
-
P1095: COVID-19 VACCINE RESPONSES IN FOLLICULAR LYMPHOMA: DETERMINANTS OF HUMORAL AND CELLULAR IMMUNITY IN THE PETREA TRIAL OF FRONTLINE CHEMOIMMUNOTHERAPY
著者:: Yeong Jer Lim, 等
出版事項: (2023-08-01) -
Interim Positron Emission Tomography During Frontline Chemoimmunotherapy for Follicular Lymphoma
著者:: Reid W. Merryman, 等
出版事項: (2023-02-01) -
Follicular Lymphoma in Chile in the Adult Public Cancer Program: The Impact of Chemoimmunotherapy
著者:: María Elena Cabrera, 等
出版事項: (2024-09-01) -
Venous thromboembolism in primary central nervous system lymphoma during frontline chemoimmunotherapy
著者:: Hiu Lam Agnes Yuen, 等
出版事項: (2020-08-01) -
Symptomatic Follicular Lymphoma: Complete Remission After Chemoimmunotherapy with Bendamustine–Rituximab
著者:: Wulyo Rajabto, 等
出版事項: (2024-04-01)